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1. Introduction
Hemocytic immune reactions to bacterial infections 
involve direct cellular interactions between circulat-
ing hemocytes and bacteria. Specific cellular defense 
mechanisms include phagocytosis and nodulation 
(Gupta, 1991). While humoral and hemocytic immune 
reactions to bacterial infections are well documented, 
until recently, when there was virtually no informa-
tion on the biochemical events responsible for medi-
ating insect immune reactions. Drawing on the back-
ground of signal transduction systems in mammalian 
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Abstract
Nodulation is the first, and qualitatively predominant, cellular defense reaction to bacterial infections in insects. 
We tested the hypothesis that eicosanoids also mediate nodulation reactions to bacterial challenge in adults of a 
social insect, the honey bee, Apis mellifera. Treating newly-emerged experimental bees with the eicosanoid bio-
synthesis inhibitor, dexamethasone, impaired nodulation reactions to bacterial infections, and the influence of 
dexamethasone was reversed by treating infected insects with arachidonic acid, an eicosanoid precursor. Sev-
eral other eicosanoid biosynthesis inhibitors, including the cyclooxygenase inhibitor, indomethacin, and the 
dual cyclooxygenase/lipoxygenase inhibitor, phenidone, also impaired the ability of experimental honeybees 
to form nodules in reaction to bacterial challenge. The influence of phenidone on nodulation was expressed in 
a dose-dependent manner. However, in experiments with older honey bees foragers, similar bacterial challenge 
did not evoke nodulation reactions. We infer from our results that while eicosanoids mediate cellular immune 
responses to bacterial infections in newly emerged honey bees, and more broadly, in most insect species, nodu-
lation reactions to bacterial challenge probably do not occur in all phases of insect life cycles.
Keywords: eicosanoids, bacterial infection, insect immunity, honey bees
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immunity, Stanley-Samuelson et al. (1991) suggested 
insect cellular immune reactions are mediated by 
eicosanoids. Eicosanoids are oxygenated metabolites 
of arachidonic acid and two other polyunsaturated 
fatty acids ( Figure 1), the structures and biosynthe-
sis of which are outlined elsewhere (Stanley, 2000). 
Eicosanoids are very well understood in the contexts 
of human and animal medicine, where they influence 
many pathophysiological events, including inflam-
mation. Beyond their actions in mammals, recogni-
tion of the biological significance of eicosanoids in in-
vertebrates is steadily growing, as detailed in recent 
reviews ( Stanley and Howard, 1998; Howard and 
Stanley, 1999; Stanley, 2000).
Figure 1. An overview of 20:4n-6 metabolism as understood 
from mammalian physiology. Three polyunsaturated fatty ac-
ids, 20:3n-6, 20:4n-6 and 20:5n-3 are potential substrates for 
eicosanoid biosynthesis. Of these, metabolism of 20:4n-6 is 
most well studied. Chemical structures are denoted by nu-
merals. 1=a cellular phospholipid; 2=hydrolyzed 20:4n-6; 
3=prostaglandin E2; 4=5-hydroperoxyeicosatetraenoic acid; 
5=leukotriene B4; 6=11,12-epoxyeicosatrienoic acid; and 7=li-
poxin A. Capital letters indicate major enzyme systems re-
sponsible for eicosanoid biosynthesis. A=phospholipase A2; 
B=cyclooxygenase and associated enzyme steps; C=cytochrome 
P450 epoxygenase; and D=lipoxygenase.
In our initial investigations into the possible roles of 
eicosanoids in invertebrate immunity, we determined 
that treating tobacco hornworms, Manduca sexta, with 
pharmaceutical inhibitors of eicosanoid biosynthe-
sis rendered experimental hornworms unable to clear 
bacterial infections from hemolymph circulation. We 
inferred from these observations that some or all of 
the cellular defense reactions responsible for clearing 
bacterial infections from hemolymph are mediated by 
eicosanoids (Stanley-Samuelson et al., 1991). This was 
the first suggestion of a signal transduction system in 
invertebrate cellular immunity.
Nodulation is an insect cellular defense reaction 
responsible for clearing large numbers of bacterial 
cells from circulation during the first 2 h of an infec-
tion (Horohov and Dunn, 1983). Because nodulation 
is the predominant cellular reaction to bacterial infec-
tions, we hypothesized that eicosanoids mediate nod-
ulation reactions to bacterial infections. We tested this 
idea by injecting hornworms with an eicosanoid bio-
synthesis inhibitor, then infecting them with bacte-
ria. Compared to ethanol-treated controls, the exper-
imental larvae produced significantly fewer nodules 
in response to similar bacterial challenges. Moreover, 
the influence of the eicosanoid biosynthesis inhibitor, 
dexamethasone, could be reversed by treating the ex-
perimental larvae with arachidonic acid, the imme-
diate precursor of eicosanoids. These findings sup-
ported the idea that nodulation is one of the cellular 
immune responses to bacterial infections that is me-
diated by eicosanoids ( Miller et al., 1994).
On the basis of these findings in a single lep-
idopteran species, we developed the hypothe-
sis that eicosanoids mediate nodulation reactions 
to bacterial infections in most, if not all, insect spe-
cies, which for convenience we refer to as the eico-
sanoid hypothesis (Stanley and Howard, 1998; Stan-
ley, 2000). Using similar experimental protocols, we 
have obtained comparable results with several in-
sect species, including the tenebrionid beetle, Zopho-
bas atratus (Miller et al., 1996), the silkworm, Bom-
byx mori (Stanley-Samuelson et al., 1997) the larvae 
of two other moths, black cutworms, Agrotis ipsilon 
and true armyworms, Pseudaletia unipuncta (Jurenka 
et al., 1997), adults of the cricket, Gryllus assimilis 
(Miller et al., 1999), the cockroach, Periplaneta ameri-
cana (Tunaz and Stanley, 1999) and the 17-year peri-
odical cicadas, Magicicada septendecim and M. cassini 
(Tunaz et al., 1999). In related work, Mandato et al. 
(1997) found that cell spreading and prophenoloxi-
dase activation, two distinct phases of nodulation, as 
well as another cellular defense reaction, phagocyto-
sis, also are mediated by eicosanoids in waxmoths, 
Galleria mellonella. These findings uniformly support 
the eicosanoid hypothesis.
Such positive support notwithstanding, innate 
immunity can be regarded as an adaptive trait 
whose expression is linked to life-history (Dunn, 
1990). Under this view, there remains the question 
of whether all insects are competent to mount cellu-
lar defense reactions. In this paper we report on ex-
periments designed to test the eicosanoid hypothe-
sis in a social insect, the honey bee, Apis mellifera. We 
observed nodulation reactions to bacterial infections 
in newly-emerged adults, and found that these reac-
tions depend on eicosanoid biosynthesis. However, 
we were unable to record nodulation reactions to 
bacterial challenge in older adults, those which had 
reached the age of foragers. We infer that the eico-
sanoid hypothesis is a useful organizing concept in 
insect immunity, however, it must be taken within 
the broader idea that the various expressions of in-
sect immunity are adaptive traits which may or may 
not be present in any given life-history stage within 
a species.
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2. Materials and methods
2.1. Organisms
Honey bees, A. mellifera, were taken from hives main-
tained on the University of Nebraska, Lincoln, cam-
pus during late summer. Pupae were removed from 
combs and used immediately. Newly-emerged adult 
bees were taken from combs within 24 h of emer-
gence. Foraging bees were captured near the en-
trances of their hives.
Cultures of a pigmented strain of the bacterium 
Serratia marcescens were taken from the microbe col-
lection at UNL, and nutrient broth (Difco) was pur-
chased from Carolina Biological Supply (Burlington, 
NC). Bacteria were grown in 50 ml of nutrient broth 
in an environmental shaker at 37°C and 100 rev./min. 
The bacteria were freeze-dried, and this material was 
taken up into pyrogen-free water for injection into the 
bees.
2.2. Injections and assays for nodulation
We followed the protocols formalized by Miller and 
Stanley (1998). Before injections, the bees were chilled, 
and then surface sterilized by swabbing their cuticle 
with 95% ethanol. We injected adults with either the 
phospholipase A2 (PLA2) inhibitor dexamethasone 
{(11β, 16α)-9-fluoro-11,17,21-trihydroxy-16-methyl-
pregna-1,4-dione}, the cyclooxygenase inhibitor in-
domethacin {1-P-(chlorobenzyl)-5-methoxy-2-methyl-
3-indolyl-acetic acid} or the dual cyclooxygenase and 
lipoxygenase inhibitor phenidone {1-phenyl-3-pry-
azolidinone} (all inhibitors purchased from BioMol, 
Plymouth Meeting, PA). In rescue experiments, adults 
were injected also with arachidonic acid {5,8,11,14-
eicosatetraenoic acid}, purchased from Sigma Chem-
ical Co. (St. Louis, MO). Control insects were injected 
with 95% ethanol. Drugs and control substances were 
injected into the opposite side of the abdomen using a 
10-μl Hamilton 701 syringe. All injections of pharma-
ceuticals were in a standard dosage of 52 μg in 4 μl 
of ethanol, except in dose–response experiments. The 
fatty acids were injected at dosages of 20 μg in 2 μl 
ethanol per adult honey bee.
Immediately after the drug injections, bees were 
challenged by injecting 50 μg of freeze-dried bac-
terial preparation, made up in pyrogen-free water, 
into each bee, following injection protocols of Miller 
and Stanley (1998). Bacteria were injected in 10-μl al-
iquots, using a 26 gauge 0.5-inch needle attached to a 
50-μl syringe (Hamilton, Reno, NV).
We assessed nodulation at selected times post-in-
fection (PI). We anesthetized the bees by chilling 
them on ice, and then exposed their hemocoels. Mela-
nized, black nodules were counted under a stereo mi-
croscope at 60×. The nodules were distinct, and direct 
counting reliably reflected the extent of the nodula-
tion response to infections (Miller and Stanley, 1998). 
After the first counting, the alimentary canal was re-
moved. Nodules in the previously unexposed areas 
and remaining internal tissues were then counted and 
the two counts were summed.
2.3. Control experiments
We conducted control experiments to register the 
background numbers of nodules in honey bees. To 
record the nodulation in unchallenged adults, 19 bees 
were taken from culture at various times in this proj-
ect. We anesthetized bees on ice for 10 min, then as-
sessed nodulation. To determine the influence of 
the drug vehicle, ethanol, on nodule formation, four 
adults were injected with 4 μl of ethanol. Nodulation 
was assessed 4 h later, following the standard proto-
col. To assess the effect of the pharmaceutical prod-
ucts on nodulation in unchallenged bees, a standard 
dosage of phenidone, in 4 μl of ethanol was injected 
into four bees. Nodulation was assessed by standard 
methods 4 h later. Finally, we tested the possibility 
that water or simple wounding could stimulate nod-
ulation by injecting 4 μl of water into five honey bees 
or piercing the integument of four honey bees. Nodu-
lation was assessed by standard methods 4 h later.
2.4. Dose–response curve for freeze-dried bacteria
The freeze-dried bacterial preparation was made up 
in pyrogen-free water in four concentrations, 5, 10, 
25, and 50 μg per injection. Newly-emerged honey 
bees were anesthetized, sterilized and injected as de-
scribed. Nodulation was assessed 4 h later.
2.5. Time course of nodulation: influence of 
phenidone
Individuals in two groups of bees were injected with 
4 μl of ethanol or with 52 μg of phenidone in 4 μl of 
ethanol. The bees were immediately injected with 
bacteria as described. At 1, 2, and 4-h PI, sub-groups 
of control and experimental insects were anesthe-
tized, and nodulation was assessed.
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2.6. Dose–response curve for phenidone
Individuals in four groups of bees were injected with 
4 μl of ethanol, or 0.52, 5.2, or 52 μg of phenidone in 
4 μl of ethanol, then challenged with a standard solu-
tion of freeze-dried bacteria. At 4-h PI, the bees were 
anesthetized, and nodulation was assessed.
2.7. Influence of other eicosanoid biosynthesis inhibi-
tors on nodulation
We divided bees into two groups and injected indi-
viduals in each group with either the cyclooxygenase 
inhibitor indomethacin, or the dual cyclooxygenase/
lipoxygenase inhibitor phenidone, in standard dos-
ages of 52 μg in 4 μl of ethanol. Control insects were 
injected with 4 μl of ethanol. Following injections, the 
bees were infected with a standard dosage of bacte-
ria as described. At 4-h PI, the bees were anesthetized 
and nodulation was assessed.
2.8. Fatty acid rescue experiment
Individuals in two groups of adult bees were injected 
with either 4 μl of ethanol or 52 μg of dexametha-
sone in 4 μl of ethanol and then infected with bacteria 
as described. Immediately after challenge, the dexa-
methasone-treated bees were divided into two sub-
groups. Individuals in one sub-group were treated 
with 20 μg of arachidonic acid in 2 μl of ethanol. An-
other sub-group was treated with 2 μl of ethanol to 
control for the effects of the extra injection on nodu-
lation. At 4-h PI, bees were anesthetized and nodula-
tion assessed.
2.9. Determining biosynthesis of prostaglandins by 
abdominal preparations from newly-emerged honey 
bees
We investigated eicosanoid biosynthesis by micro-
somal-enriched preparations of gut-free honey bee 
bodies. These experiments followed protocols de-
veloped for fat body from M. sexta (Stanley-Samu-
elson and Ogg, 1994). Briefly, tissues prepared from 
15 honey bees were mechanically ground using a 1-
ml glass homogenizer. The homogenates were son-
icated for 40 s at 30 W using a VibraCell sonicator 
(VibraCell, Danbury, CT). This preparation was cen-
trifuged for 10 min at 735×g, and the supernatant 
was centrifuged for another 20 min at 16 000×g, both 
steps at 4°C. The 16 000×g supernatants were mi-
crosomal-enriched preparations used in all experi-
ments. Protein concentrations in these preparations 
were determined as described by Stanley-Samuel-
son and Ogg (1994).
Radioactive arachidonic acid (5,6,8,9,11,12,14,15-
[3H]-20:4, 60–100 Ci/mmol) was purchased from Du-
Pont. The incubation buffer was 0.05 M KH2PO4, pH 
8.0, amended with a standard co-factor cocktail (2.4 
mM reduced glutathione, 0.25 mM hydroquinone 
and 25 μg hemoglobin per reaction). For each PG 
biosynthesis reaction, 0.4 μCi of labeled arachidonic 
acid was dispensed into reaction tubes and the sol-
vent was evaporated. The reactions were carried out 
in 1.0-ml total volume. The experiments were pre-
ceded by a 10-min pre-incubation at 32°C with all re-
action components, except the protein source. After 
a 2-min reaction period at 32°C, the reactions were 
stopped by addition of 500 μl 0.1 N HCl. Reaction 
products were extracted from the acidified reaction 
mixture three times in ethyl acetate. The combined 
extracts, containing PGs and possibly lipoxygen-
ase products, were evaporated under N2. A mix-
ture of appropriate eicosanoid standards was added 
to each sample, then samples were applied to thin-
layer chromatography plates (described above). The 
plates were developed and fractions observed as de-
scribed (Stanley-Samuelson and Ogg, 1994). Bands 
corresponding in Rf to selected authentic eicosanoid 
standards and to free fatty acids were transferred to 
liquid scintillation vials. Radioactivity in each frac-
tion was determined by adding Ecolite scintillation 
cocktail (ICN Biomedicals, Irvine, CA) and counting 
on a LKB Wallac 1209 Rackbeta Liquid Scintillation 
Counter (Pharmacia, Turku, Finland) at 50% count-
ing efficiency for [3H]. Eicosanoid biosynthesis was 
calculated from the liquid scintillation data. In con-
trol experiments, microsomal-enriched preparations 
were heated in boiling water for 15 min before the 
experiments, and processed as just described. The 
results of these control experiments were used to 
correct values from biosynthesis experiments.
2.10. Statistical analysis
Nodulation data were analyzed by analysis of vari-
ance in the General Linear Models procedure, and 
mean comparisons were made using the Least Sig-
nificant Difference (LSD) test (SAS Institute Inc., 
1989).
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3. Results
3.1. Control experiments
Table 1 displays the results of control experiments. 
We recorded less than one nodule/bee (n=19 honey 
bees) in untreated insects taken directly from the cul-
ture. Injections with water resulted in approximately 
four nodules/insect, and simple wounding induced 
virtually no nodulation. Similarly, we observed ap-
proximately eight nodules/insect in bees injected 
with phenidone. Pure ethanol seemed to induce a 
moderate level of nodulation because we recorded 
46 nodules/insect in bees injected with ethanol. By 
comparison, challenges with standard dosages of 
the freeze-dried S. marcescens, prepared in pyrogen-
free water, resulted in approximately 134 nodules per 
adult.
3.2. Dose–response curve for S. marcescens
We recorded increased nodulation with increas-
ing doses of the freeze-dried bacterial preparation, 
from approximately 10 nodules/insect at the low-
est dose to approximately 50 nodules/insect at the 
highest dose (Figure 2). As a practical matter, these 
data informed our use of 50 μg/insect in subsequent 
experiments.
3.3. Time course of nodulation
The time course of visible nodule formation in two 
groups of bees, experimentals and controls, is shown 
in Figure 3. Phenidone-treated adults formed ap-
proximately three nodules/insect at 1-h PI, which in-
creased to seven at 2-h PI, and to approximately 11 at 
4 h. The ethanol-treated control adults produced 20 
nodules at 1-h PI and 32 at 2-h PI. By 4-h PI, the con-
trol bees yielded significantly more nodules, approxi-
mately 130/insect.
3.4. Dose–response curve for phenidone
The influence of phenidone on nodulation in response 
to bacterial infections was expressed in a dose-depen-
dent manner (Figure 4). Nodulation declined from 
approximately 130 nodules/bee in ethanol-treated 
control bees, to approximately 11 nodules/insect in 
bees treated with the highest phenidone dosage (Fig-
ure 4). Intermediate dosages produced intermediate 
nodulation reactions.
3.5. Influence of other eicosanoid biosynthesis inhibi-
tors on nodulation
We considered the influence of three pharmaceuti-
cal inhibitors of eicosanoid biosynthesis on nodu-
lation in response to bacterial infections (Figure 5). 
Compared to control (EtOH) bees, all experimental 
bees exhibited significantly reduced nodulation in 
response to bacterial infections (LSD, P<0.05). We 
obtained significant differences between the influ-
ence of phenidone, which severely inhibited nodule 
formation, and the influences of indomethacin and 
dexamethasone.
3.6. Arachidonic acid reversed the influence of dexa-
methasone on nodulation
According to the evidence taken from research in 
mammalian physiology, dexamethasone, as one of 
its actions, inhibits eicosanoid biosynthesis through 
its effect on PLA2. On this idea, injecting the eico-
sanoid-precursor polyunsaturated fatty acid, ara-
chidonic acid, into dexamethasone-treated infected 
adults should reverse the effects of dexamethasone 
on nodulation. We used the following protocol to test 
this. After injection with dexamethasone, adults were 
infected with bacteria and then immediately treated 
Table 1. Outcomes of background control experiments a
Treatment                  Number of          Nodules per bee
                                    individuals          (mean ± S.E.M.)
No treatment  19  0.05 ± 0.05
Inject EtOH  4  46.2 ± 12.4
Inject water  5  3.6 ± 1.0
Bacterial challenge  15  133.9 ± 11.7
Wound with needle  4  0.2 ± 0.2
Inject phenidone  4  7.7 ± 3.9
a Newly-emerged honey bees were treated as speci-
fied in the left column, and nodulation was assessed at 
4-h post-treatment, except for bees taken directly from 
combs to assess nodulation in untreated individuals. 
The phenidone was dissolved in 95% EtOH, and the ve-
hicle control was 95% EtOH. The bacterial challenge was 
our standard dosage of freeze-dried bacteria prepared in 
pyrogen-free water.
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with arachidonic acid. To control for the influence of 
the third injection on nodulation, an additional con-
trol group of bees was injected with ethanol. As can 
be seen in Figure 6, arachidonic acid treatments re-
versed the effects of dexamethasone on nodula-
tion (LSD, P<0.05). The ethanol-injected control bees 
yielded approximately 160 nodules/honey bee and 
dexamethasone-treated bees approximately 37 nod-
ules/honey bee, both in line with expectation. The ar-
achidonic acid-treated bees produced approximately 
190 nodules/bee, also in line with expectation for 
control animals. The second control group, injected 
with a second dose of ethanol, yielded approximately 
50 nodules/bee.
3.7. The influence of age on nodulation reactions to 
bacterial challenge
Newly-emerged honey bees produced high num-
bers of nodules, usually well over 130 nodules/bee, 
Figure 1. An overview of 20:4n-6 metabolism as understood from mammalian physiology. Three polyunsaturated fatty acids, 
20:3n-6, 20:4n-6 and 20:5n-3 are potential substrates for eicosanoid biosynthesis. Of these, metabolism of 20:4n-6 is most well 
studied. Chemical structures are denoted by numerals. 1 a cellular phospholipid; 2 hydrolyzed 20:4n-6; 3 prostaglandin E2 ; 4 5-
hydroperoxyeicosatetraenoic acid; 5 leukotriene B4; 6 11,12-epoxyeicosatrienoic acid; and 7 lipoxin A. Capital letters indicate major 
enzyme systems responsible for eicosanoid biosynthesis. A phospholipase A2 ; B cyclooxygenase and associated enzyme steps; 
C cytochrome P450 epoxygenase; and D lipoxygenase.
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in reaction to our standard challenge. The situa-
tion was entirely different for older, foraging honey 
bees. At 4 h after injection with our standard bacterial 
challenge, we recorded no nodules in foragers. This 
seemed a little odd, compared to our results with 
younger bees, and we investigated the point a little 
further. While we were able to withdraw hemolymph 
and register the presence of hemocytes with younger 
bees, we were not able to withdraw hemolymph from 
foragers.
Figure 5. Effect of treating honey bees with individual eico-
sanoid biosynthesis inhibitors on nodule formation in re-
sponse to intrahemocoelic infections with the insect patho-
gen, S. marcescens. Test insects were first injected with 52 μg 
of either dexamethasone (Dex, PLA2 inhibitor), indomethacin 
(Indo, cyclooxygenase inhibitor) or phenidone (phen, dual cy-
clooxygenase/lipoxygenase inhibitor), then challenged with 
intrahemocoelic injections of freeze-dried bacteria, S. marsce-
scens. Control insects were first injected with ethanol (EtOH), 
then similarly challenged. Nodulation was assessed at 4-h PI. 
The height of the histogram bars represents the mean number 
of nodules found in each insect and the error bars represent 1 
S.E.M. The number in parentheses represents the number of 
individuals in each treatment. Histogram bars with the same 
fill pattern are not significantly different from each other (LSD, 
P<0.01).
Figure 3. Time course of nodulation in adult honey bees, A. 
mellifera, in response to intrahemocoelic challenge with freeze-
dried pathogenic bacterium, S. marcescens. Control insects 
were first treated with ethanol, then injected with bacteria and 
experimental insects were first treated with phenidone, then 
injected with bacteria. Each point indicates the mean number 
of nodules found at the indicated times PI in each insect (n=5 
or 6 individuals), and the error bars represent 1 S.E.M.
Figure 2. The influence of freeze-dried bacteria, S. marcescens, 
on nodulation reactions in adult honey bees, A. mellifera, was 
expressed in a dose-dependent manner. Bees were challenged 
with injection of the indicated dosages of freeze-dried bacte-
rial, prepared in water, then nodulation was recorded at 4-h 
PI. Each point indicates the mean number of nodules found 
in each insect (n=6 individuals), and the error bars represent 
1 S.E.M.
Figure 4. Dose–response curve for the influence of pheni-
done on nodule formation in adult honey bees. Individuals 
in four groups of bees were first treated with indicated dos-
ages of phenidone, then challenged with intrahemoceolic in-
jections of freeze-dried bacteria, S. marcescens. Nodulation was 
assessed at 4-h PI. Each point indicates the mean number of 
nodules found in each insect (n=6) and the error bars repre-
sent 1 S.E.M.
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3.8. Eicosanoid biosynthesis by abdominal tissues
The gut-free bodies of newly-emerged adult honey 
bees converted arachidonic acid into two prostaglan-
dins, PGA2 (1.05 pmol/mg protein/h) and PGF2α 
(0.07 pmol/mg protein/h). As seen in many insect 
preparations, PGA2 appears to be the predominant 
product.
4. Discussion
In this paper we report on the outcomes of experi-
ments designed to test the eicosanoid hypothesis in 
adults of the honey bee, Apis mellifera. The results of 
all experiments support the hypothesis for newly-
emerged, but not for foraging bees. First, treating ex-
perimental bees with phenidone prior to challenging 
them with freeze-dried bacterial preparations signif-
icantly reduced nodulation at all points in the time 
course experiments. Second, the influence of pheni-
done on nodulation was expressed in a dose–depen-
dent manner. Third, three different eicosanoid bio-
synthesis inhibitors significantly reduced nodulation 
relative to control treatments. Fourth, the influence of 
dexamethasone on nodulation was reversed by treat-
ing infected bees with arachidonic acid. Finally, we 
found that gut-free tissue homogenates were able to 
convert arachidonic acid into two prostaglandins. 
This indicates that honey bee tissues express the en-
zymes required for eicosanoid biosynthesis. Taken to-
gether, these separate lines of evidence strongly sup-
port the overall hypothesis.
The results of the time course experiment indicate 
that bees treated with phenidone produced signifi-
cantly fewer nodules than the control bees at all time 
points in the experiment. We infer from this finding 
that inhibition of eicosanoid biosynthesis influences 
the cellular events involved in nodulation early in the 
infection process, and continues to exert a negative 
influence for many hours PI.
The time course experiment also indicates the up-
per limits of nodulation reactions to bacterial infec-
tions in bees. The experimental honey bees produced 
a maximum of approximately 130 nodules/individ-
ual by 4-h PI. This value is in line with the outcomes 
of similar experiments with other insect species. Lar-
vae of the tenebrionid beetle, Z. atratus produced ap-
proximately 50 nodules/individual at 6-h after infec-
tion with the same number of bacterial cells (Miller et 
al., 1996). The larvae of several Lepidoptera produced 
more nodules in response to similar challenges. To-
bacco hornworms, M. sexta yielded approximately 
120 nodules/individual by 6-h PI (Miller et al., 1994), 
and silkworms, B. mori, formed approximately 80 
nodules/individual at 15-h PI (Stanley-Samuelson et 
al., 1997). In our work with another hemimetabolous 
species, Miller et al. (1999) recorded approximately 45 
nodules at 4-h PI in identical experiments with adult 
crickets, G. assimilis.
Howard et al. (1998) suggested that differences in 
nodulation intensity might be due to differences in 
circulating hemocyte populations. In work with to-
bacco hornworms and larvae of Z. atratus, Howard 
et al. (1998) recorded numbers of nodules formed in 
reaction to similar bacterial challenges as a function 
of insect size, weight and age. These experiments 
showed that nodulation was not influenced by these 
three parameters. Noting that insects tend to main-
tain fairly similar concentrations of circulating he-
mocytes (approximately 4–6×106 cell/ml hemo-
lymph), those insect species with copious amounts 
of hemolymph, such as tobacco hornworms, would 
have far larger absolute numbers of circulating he-
Figure 6. The eicosanoid-precursor fatty acid, arachidonate, 
reversed the effect of dexamethasone on nodulation in adults 
of A. mellifera. Honey bees were treated with ethanol (EtOH) 
or dexamethasone (Dex) and then challenged with intrahemo-
coelic injections of freeze-dried bacteria, S. marcescens. Imme-
diately after challenge, test insects were treated with 20 μg of 
arachidonic acid (Dex+AA). Control insects were treated with 
dexamethasone and ethanol (Dex+EtOH). The height of histo-
gram bars represents the mean number of nodules found at 4-
h PI in each insect (n=6 individuals) and the error bars repre-
sent 1 S.E.M. Histogram bars with the same fill pattern are not 
significantly different from each other (LSD, P<0.01).
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mocytes. The authors speculated that if circulating 
hemocyte population sizes account for differences in 
nodulation capacity, then, it should not be surpris-
ing to record considerable differences among insect 
species in nodulation responses to similar infection 
challenges.
These comments are germane to our finding that 
older, foraging honey bees did not form visible nod-
ules in reaction to bacterial challenge. We were un-
able to prepare hemolymph samples from foragers, 
even at the μl scale, from which we inferred that older 
honey bees have very few circulating hemocytes. The 
very low, for practical purposes, absent volumes of 
collectable hemolymph, with attendant low popula-
tions of circulating hemocytes, may be a form of im-
mune senescence. Honey bees go through a lengthy 
excursion of age-related tasks, beginning with in-hive 
tasks such as tending brood and comb building and 
ending with outside tasks, including ventilating and 
finally foraging. While newly-emerged and cell-clean-
ing bees do not overlap in age with foragers, there is 
considerable overlap in age-related task performance 
(Winston, 1987). The mean age at first foraging is ap-
proximately 23 days, ranging from 18 to 28 days, 
which overlaps the age of several advanced in-hive 
tasks. Immune senescence may occur in honey bees, 
however, until this is investigated in more detail, it 
cannot be said whether the phenomenon is linked to 
physiological age or the onset of a certain category of 
tasks, such as outside tasks.
We considered influence of phenidone dosage on 
nodulation reactions to similar bacterial challenges. 
Dose–response relationships are basic to physiolog-
ical research, and the approximately linear negative 
relationship we obtained for phenidone strongly sup-
ports the idea that eicosanoids mediate nodulation re-
actions to bacterial infections in the honey bee.
Due to their importance in human medicine, many 
different inhibitors of eicosanoid biosynthesis are 
available. Some, such as aspirin and ibuprofen, are 
available as analgesic drugs for relief of minor pains, 
while many others are not yet approved for use in 
humans. These compounds, which we refer to with 
the general term ‘eicosanoid biosynthesis inhibitors’, 
exert different actions in cellular eicosanoid biosyn-
thesis. For example, dexamethasone inhibits PLA2. 
Dexamethasone exerts other actions, as well, includ-
ing influence on gene expression. Several compounds 
specifically inhibit cyclooxygenase, the first step in 
prostaglandin biosynthesis (Figure 1). Our experi-
ments with different inhibitors showed that all three 
of the compounds we tested resulted in similar reduc-
tions in nodulation. The observation that separate ex-
periments with different inhibitors of eicosanoid bio-
synthetic pathways similarly retarded nodulation in 
adult honey bees indicate that eicosanoids act in nod-
ule formation.
The results of the rescue experiments strongly sup-
port our hypothesis that eicosanoids mediate nodula-
tion in honey bees. Dexamethasone is thought to act 
by inhibiting PLA2, the enzyme responsible for re-
leasing arachidonic acid from cellular phospholipids. 
This is the first and rate-limiting step in eicosanoid 
biosynthesis. Dexamethasone inhibits eicosanoid bio-
synthesis by inhibiting the release of substrate from 
cellular phospholipids, which in effect withholds 
substrate from cyclooxygenase and other eicosanoid 
biosynthesizing enzymes. If this is so, then provid-
ing arachidonic acid to the immunity-conferring cells 
within the honey bees would be expected to reverse 
the influence of dexamethasone on nodulation. In-
deed, the arachidonic acid treatments restored the 
honey bees’ ability to produce nodules in response to 
bacterial infections.
Stanley-Samuelson (1994) indicated that experi-
ments with eicosanoid biosynthesis inhibitors were 
based, in part, on the assumption that the exper-
imental insects were competent to biosynthesize 
eicosanoids. The presence of eicosanoid precursor 
polyunsaturated fatty acids and the enzymes re-
sponsible for eicosanoid biosynthesis have been doc-
umented for honey bees ( Stanley-Samuelson and 
Dadd, 1983). In this paper, we document the pres-
ence of eicosanoid biosynthesizing enzymes in fat 
body of adult honey bees. The honey bee prepara-
tions yielded PGA2 (at approx. 1.05 pmol/mg pro-
tein/h) as the major product. Rates of prostaglandin 
biosynthesis recorded from in vitro insect prepa-
rations are typically low, and the values recorded 
with honey bee preparations are similar to values 
recorded from larvae of the butterfly, Colias eury-
theme (Stanley-Samuelson et al., 1997) and adults of 
cicadas, Magicicada septendecim (Tunaz et al., 1999). 
Hence, a basic assumption of this line of experimen-
tation has been met.
Our background control experiments indicate 
that the nodules we recorded were due to the ex-
perimental treatments, and not to adventitious in-
fections. Honey bees taken directly from the colony 
had a low background of nodulation. The injec-
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tion treatments, similarly, did not influence the low 
background of nodulation. We note that control ex-
periments with ethanol yielded higher numbers 
of nodules than recorded with other insect species 
(Miller et al., 1994, 1996), however, the key point is 
that the drug vehicle did not, in itself, diminish the 
bees’ ability to form nodules. We note that control 
treatments with phenidone in the vehicle yielded 
very few nodules, indicating that the ethanol-in-
duced nodulation also is mediated by eicosanoids. 
We infer that the experimental protocols allow a 
physiological interpretation of the data, inhibition 
of eicosanoid biosynthesis impairs immunity in 
newly-emerged honey bees.
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